The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
NDAQ:SLDB) Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich's Ataxia ...
President Trump has announced a national emergency focused on border security, aiming to curb illegal migration and drug ...
Koh Young Technology gains FDA approval for medical robot in brain surgery Koh Young Technology secures FDA clearance for innovative robotic system in neurosurgery ...
The U.S. Drug Enforcement Administration warns that “virtual currency continues to be a popular and growing method used to ...
On Wednesday, the Food & Drug Administration (FDA) banned red dye No. 3 from all food products in the United States due to potential cancer risk, but this raises an important ...